Systemic corticosteroid therapy for acute asthma exacerbations

Stanley Fiel, Walter Vincken

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Acute exacerbations of asthma may represent reactions to airway irritants or failures of chronic treatment. The costs to both the patient and society are high. Exacerbations often are frightening episodes that can cause significant morbidity and sometimes death. The emergency department (ED) visits and hospitalizations often required lead to significant health care expenses. Thus, preventing and optimizing management of acute exacerbations is critical. Corticosteroids are a cornerstone of asthma therapy. They have been shown to lower admission rates and reduce risk of relapse. This article provides an overview of the role of corticosteroids (including betamethasone, dexamethasone, methylprednisolone, and prednisolone) in the management of acute asthma exacerbations, with an aim toward effective decision making about the choice of therapy.

Original languageEnglish (US)
Pages (from-to)321-331
Number of pages11
JournalJournal of Asthma
Volume43
Issue number5
DOIs
StatePublished - Jul 1 2006
Externally publishedYes

Fingerprint

Adrenal Cortex Hormones
Asthma
Betamethasone
Irritants
Methylprednisolone
Prednisolone
Treatment Failure
Dexamethasone
Hospital Emergency Service
Decision Making
Hospitalization
Therapeutics
Morbidity
Delivery of Health Care
Costs and Cost Analysis
Recurrence

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Fiel, Stanley ; Vincken, Walter. / Systemic corticosteroid therapy for acute asthma exacerbations. In: Journal of Asthma. 2006 ; Vol. 43, No. 5. pp. 321-331.
@article{2e33b76f84394d719838fa8f764bd82a,
title = "Systemic corticosteroid therapy for acute asthma exacerbations",
abstract = "Acute exacerbations of asthma may represent reactions to airway irritants or failures of chronic treatment. The costs to both the patient and society are high. Exacerbations often are frightening episodes that can cause significant morbidity and sometimes death. The emergency department (ED) visits and hospitalizations often required lead to significant health care expenses. Thus, preventing and optimizing management of acute exacerbations is critical. Corticosteroids are a cornerstone of asthma therapy. They have been shown to lower admission rates and reduce risk of relapse. This article provides an overview of the role of corticosteroids (including betamethasone, dexamethasone, methylprednisolone, and prednisolone) in the management of acute asthma exacerbations, with an aim toward effective decision making about the choice of therapy.",
author = "Stanley Fiel and Walter Vincken",
year = "2006",
month = "7",
day = "1",
doi = "10.1080/02770900600567163",
language = "English (US)",
volume = "43",
pages = "321--331",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "5",

}

Systemic corticosteroid therapy for acute asthma exacerbations. / Fiel, Stanley; Vincken, Walter.

In: Journal of Asthma, Vol. 43, No. 5, 01.07.2006, p. 321-331.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Systemic corticosteroid therapy for acute asthma exacerbations

AU - Fiel, Stanley

AU - Vincken, Walter

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Acute exacerbations of asthma may represent reactions to airway irritants or failures of chronic treatment. The costs to both the patient and society are high. Exacerbations often are frightening episodes that can cause significant morbidity and sometimes death. The emergency department (ED) visits and hospitalizations often required lead to significant health care expenses. Thus, preventing and optimizing management of acute exacerbations is critical. Corticosteroids are a cornerstone of asthma therapy. They have been shown to lower admission rates and reduce risk of relapse. This article provides an overview of the role of corticosteroids (including betamethasone, dexamethasone, methylprednisolone, and prednisolone) in the management of acute asthma exacerbations, with an aim toward effective decision making about the choice of therapy.

AB - Acute exacerbations of asthma may represent reactions to airway irritants or failures of chronic treatment. The costs to both the patient and society are high. Exacerbations often are frightening episodes that can cause significant morbidity and sometimes death. The emergency department (ED) visits and hospitalizations often required lead to significant health care expenses. Thus, preventing and optimizing management of acute exacerbations is critical. Corticosteroids are a cornerstone of asthma therapy. They have been shown to lower admission rates and reduce risk of relapse. This article provides an overview of the role of corticosteroids (including betamethasone, dexamethasone, methylprednisolone, and prednisolone) in the management of acute asthma exacerbations, with an aim toward effective decision making about the choice of therapy.

UR - http://www.scopus.com/inward/record.url?scp=33745726753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745726753&partnerID=8YFLogxK

U2 - 10.1080/02770900600567163

DO - 10.1080/02770900600567163

M3 - Article

C2 - 16801135

AN - SCOPUS:33745726753

VL - 43

SP - 321

EP - 331

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 5

ER -